Dare Bioscience DARE
NASDAQ DARE
$0.70 +0.01 (+1.16%)
As of: Nov 11, 2026 · 10:05 AM EST

Dare Bioscience (DARE) Gross Margin (2025 - 2026)

Updated

Dare Bioscience's Gross Margin came in at -70.57% for Q2 2026.

Analysis

Dare Bioscience (DARE) Gross Margin (2025 - 2026) Analysis & Trends

For FY2025, Dare Bioscience's Gross Margin was 71.29%, down 28.71 percentage points from FY2024.

  • Going back by year, Gross Margin was 100.00% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 68.12%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 75.38%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 72.95%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.03%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 73.10%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 81.07%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 75.71%
10 Dare Bioscience 10.47 Mn -68.48 Mn -132,343.00 -70.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -70.57%
Mar 31, 2026 -58.95%
Jun 30, 2025 100.00%
Mar 31, 2025 100.00%
API Access

Dare Bioscience Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=DARE&period=max&api_key=YOUR_API_KEY